Journal of Substance Abuse Treatment
Volume 34, Issue 2 , Pages 249-262 , March 2008

Organizational- and individual-level correlates of posttreatment substance use: A multilevel analysis

  • Toorjo Ghose, Ph.D.

      Affiliations

    • Corresponding Author InformationCenter for Interdisciplinary Research on AIDS, Yale University, 40 Temple St., Suite 1B, New Haven, CT 06510, USA.

Received 17 November 2006 ,Revised 2 April 2007 ,Accepted 5 April 2007.

References 

  1. Agosti V, Nunes E, Ocepeck-Welikson K. Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug and Alcohol Abuse. 1996;22:29–39
  2. Alexander JA, Lemak CH. The effects of managed care administrative burden in outpatient substance abuse treatment organizations. Medical Care Research and Review. 1997;54:490–507
  3. Alexander JA, Lemak CH, Campbell CI. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995–2000. Journal of Behavioral Health Services Research. 2003;30:369–381
  4. Alexander JA, Wheeler JA, Nahra TA, Lemak CH. Managed care and technical efficiency in outpatient substance abuse treatment units. Journal of Behavioral Health Services and Research. 1998;25:377–397
  5. Anglin DM, Hser Y. Treatment of drug abuse. In:  Tonry M,  Wilson JQ editor. Drugs and Crime. Chicago: University of Chicago Press; 1990;p. 393–458
  6. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: Patients, programs, services and outcome. New York, NY: Springer-Verlag Publishing; 1991;
  7. Bernstein E, Bernstein J, Tassiopoulos K, Valentine A, Heeren T, Levenson S, et al. Racial and ethnic diversity among a heroin and cocaine using population: Treatment system utilization. Journal of Addictive Diseases. 2005;24:44–63
  8. Brennan PL, Nichol AC, Moos RH. Older and younger patients with substance use disorders: Outpatient mental health service use and functioning over a 12-month interval. Psychology of Addictive Behaviors. 2003;17:42–48
  9. Broome KM, Simpson DD, Joe GW. Patient and program attributes related to treatment process indicators in DATOS. Drug and Alcohol Dependence. 1999;7:127–135
  10. Burling TA, Reilly PM, Molten JO, Ziff D. Self-efficacy and relapse among inpatient drug and alcohol abusers: A predictor of outcome. Journal of Studies on Alcoholism. 1989;50:354–360
  11. Corcoran KJ, Vandiver V. Maneuvering the maze of managed care: A manual for mental health practitioners. New York: Free Press; 1996;
  12. Cushman P. Ten years of methadone maintenance treatment: Some clinical observations. American Journal of Drug and Alcohol Abuse. 1977;44:543–553
  13. D'Aunno T. The role of organization and management in substance abuse treatment: Review and roadmap. Journal of Substance Abuse Treatment. 2006;31:221–233
  14. D'Aunno T, Vaughn TE. An organizational analysis of service patterns in outpatient drug abuse treatment units. Journal of Substance Abuse. 1995;7:27–42
  15. D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior. 1999;40:175–192
  16. DiMaggio PJ, Powell WW. The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. American Sociological Review. 1983;48:147–160
  17. Drug and Alcohol Service Information System . Growth of managed care in substance abuse treatment. Substance Abuse and Mental Health Services Administration. Retrieved June 30, 2006 from http://oas.samhsa.gov/2k1/managedcare/managedcare.htm2001;
  18. Durkin EM. An organizational analysis of psychosocial and medical services in outpatient drug abuse treatment programs. Social Service Review. 2002;76:406–429
  19. Etheridge RM, Hubbard RL. Conceptualizing and assessing treatment structure and process in community-based drug dependency treatment programs. Substance Use and Misuse. 2000;55:1757–1795
  20. Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors. 1997;11:244–260
  21. Friedmann PD, Alexander JA, D'Aunno T. Organizational correlates of access to primary care and mental health services in drug abuse treatment units. Journal of Substance Abuse Treatment. 1999;16:71–80
  22. Friedmann PD, Durkin E, Lemon SC, D'Aunno TA. Delivery of ancillary services in outpatient substance abuse treatment programs. Journal of Substance Abuse Treatment. 2003;24:81–88
  23. Ghose T. Organizational correlates of specialized substance abuse treatment provision to seropositive clients: A political economy perspective. Journal of HIV/AIDS & Social Services. 2007;5:41–59
  24. Gold MR, Hurley R, Lake T, Ensor T, Berenson R. A national survey of the arrangements managed-care plans make with physicians. Journal of Medicine. 1995;333:1678–1683
  25. Gossop M, Stewart D, Browne N, Marsden J. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: Protective effect of coping responses. Addiction. 2002;97:1259–1267
  26. Grella CE, Joshi V, Hser Y. Followup of cocaine-dependent men and women with antisocial personality disorder. Journal of Substance Abuse Treatment. 2003;25:155–164
  27. Gronbjerg KA. Understanding nonprofit funding: Managing revenues in social services and community development organizations. San Francisco: Jossey-Bass; 1993;
  28. Gronbjerg KA. Markets, politics and charity: Nonprofits in the political economy. In:  Powell WW,  Clemens ES editor. Private action and the public good. New Haven: Yale University Press; 1998;p. 137–149
  29. Guydish J, Wardegar D, Sorenson JL, Clarke W, Acampora A. Drug abuse day treatment: A randomized clinical trial comparing day and residential treatment programs. Journal of Consulting and Clinical Psychology. 1998;66:280–289
  30. Heinrich CJ, Fournier E. Dimensions of publicness and performance in substance abuse treatment organizations. Journal of Policy Analysis and Management. 2004;23:49–63
  31. Heinrich CJ, Lynn LE. Improving the organization, management, and outcomes of substance abuse treatment programs. American Journal of Drug and Alcohol Abuse. 2002;28:601–622
  32. Hesselbrock M. Gender comparison of antisocial personality disorder and depression in alcoholism. Journal of Substance Abuse. 1991;3:205–219
  33. Hoffman JA, Caudill BD, Koman JJ, Lucky JW. Psychosocial treatments for cocaine abuse: 12-Month treatment outcomes. Journal of Substance Abuse Treatment. 1996;13:3–11
  34. Hser Y, Anglin MD, Fletcher B. Comparative treatment effectiveness: Effects of program modality and client drug dependence history on drug use reduction. Journal of Substance Abuse Treatment. 1998;15:513–523
  35. Hser Y, Evans E, Huang D, Anglin MD. Relationship between drug treatment services, retention and outcomes. Psychiatric Services. 2001;55:767–774
  36. Hser Y, Huang Y, Teruya C, Anglin MD. Gender differences in treatment outcomes over a three-year period. Journal of Drug Issues. 2004;34:419–439
  37. Hser Y, Joshi V, Anglin DM. Predicting post-treatment cocaine abstinence for first-time admissions and treatment repeaters. American Journal of Public Health. 1999;89:666–671
  38. Hser Y, Joshi V, Maglione M, Chou C, Anglin MD. Effects of program and patient characteristics on retention of drug treatment patients. Evaluation and Program Planning. 2001;24:331–341
  39. Hubbard RL, Craddock SG, Andersen J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). Journal of Substance Abuse Treatment. 2003;23:125–134
  40. Hubbard RL, Flyn PM, Craddock SG, Fletcher BW. Relapse after drug abuse treatment. In:  Tims M,  Leukefeld CG,  Platt JJ editor. Relapse and recovery in addictions. New Haven: Frank Yale University Press; 2001;p. 109–121
  41. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: A national study of effectiveness. Chapel Hill: The University of North Carolina Press; 1989;
  42. Iglehart JK. Managed care and mental health. Health Policy Report. 1996;334:131–135
  43. Johnson JA, Roman PM. Predicting closure of private substance abuse treatment facilities. Journal of Behavioral Health Services and Research. 2002;29:115–125
  44. Joint Commission on the Accreditation of Healthcare Organizations . Comprehensive accreditation manual for behavioral health care. Retrieved July 31, 2006 http://www.jointcommission.org2006;
  45. Knight DK, Logan SM, Simpson DD. Predictors of program completion for women in residential substance abuse treatment. American Journal of Drug & Alcohol Abuse. 2001;27:1–18
  46. Lee MT, Reif S, Ritter GA, Levine H, Horgan CM. Access to services in the substance abuse treatment system: Variations by facility characteristics. In:  Galanter M editors. Recent Developments in Alcoholism. Vol. 15:New York: Kluwer Academics; 2001;p. 137–156
  47. Lemak CL, Alexander JA. Managed care and drug treatment practices: A model of organizational response to external influence. Advances in Health Care Management. 2001;2:131–159
  48. Lemak CL, Alexander JA. Managed care and outpatient substance abuse treatment intensity. Journal of Behavioral Health Services and Research. 2001;28:12–29
  49. Lemak CH, Alexander JA, Campbell C. Administrative burden and its implications for outpatient substance abuse treatment organizations. Psychiatric Services. 2003;54:705–711
  50. Leukefeld C, McDonald SH, Staton M, Mateyoke-Scrivner A. Employment, employment-related problems, and drug use at drug court entry. Substance Use and Misuse. 2004;39:2559–2579
  51. Lo Sasso A, Lyons JS. The sensitivity of managed care treatment intensity to co-payment levels. Journal of Behavioral Health Services and Research. 2004;31:50–65
  52. Longest B, Rakich JS, Darr K. Managing health service organizations and systems. Baltimore, MD: Health Professionals Press; 2005;
  53. McCaul ME, Svikis D, Moore RD. Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependence. 2001;62:9–17
  54. McGlothlin WH, Anglin DM. Long-term followup of clients of high- and low-dose methadone programs. Archives of General Psychiatry. 1981;38:1055–1063
  55. McKay JR, Pettinati HM, Morrison R, Feeley M, Mulvaney FD, Gallop R. Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychology of Addictive Behaviors. 2002;16:225–235
  56. McLellan TA, Lewis D, O'Brien C, Kleber H. Drug dependence, a chronic mental illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association. 2000;284:1689–1695
  57. McLellan TA, Luborsky L, O'Brien CP. Alcohol and drug abuse treatment in three different populations—Is there improvement and is it predictable?. American Journal of Drug and Alcohol Abuse. 1986;12:101–120
  58. McLellan TA, Woody GE, Metzger D. Evaluating the effectiveness of addiction treatments: Reasonable expectations, appropriate comparisons. Milbank Quarterly. 1996;74:51–85
  59. Mechanic D, Schlesinger M, McAlpine D. Management of mental health and substance abuse services: State of the art and early results. Milbank Quarterly. 1995;73:19–55
  60. Messina N, Wish E, Nemes S. Predictors of treatment outcomes for men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse. 2000;26:207–227
  61. Meyer JW, Rowan B. Institutionalized organizations: Formal structure as myth and ceremony. American Journal of Sociology. 1977;83:340–363
  62. Milligan CO, Nich C, Carroll KM. Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials. Psychiatric Services. 2004;55:167–173
  63. Office of Applied Studies . Alcohol and Drug Services Study. Retrieved July 31, 2006 http://oas.samhsa.gov/adss.htm#Methods2005;
  64. Office of Applied Studies . Prevalence of substance abuse among racial and ethnic subgroups in the U.S.. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Rockville, MD: National Clearinghouse for Alcohol and Drug Information (NCADI); 2006;Retrieved July 31, 2006. http://www.oas.samhsa.gov/NHSDA/Ethnic/ethn1001.htm
  65. Olmstead T, White WD, Sindelar J. The impact of managed care on substance abuse treatment services. Health Services Research. 2004;39:319
  66. Orwin R, Ellis B. The National Treatment Improvement Evaluation Study: Multilevel reanalysis of treatment outcomes. Fairfax, VA: Center for Substance Abuse Treatment, National Evaluation Data and Technical Assistance Center; 2000;
  67. Orwin RG, Ellis B, Williams V, Maranda M. Relationships between treatment components, client-level factors and positive treatment outcomes. Journal of Psychopathology and Behavioral Assessment. 2000;22:383–397
  68. Pfeffer J, Salancik GR. The external control of organizations: A resource dependence perspective. New York: Harper and Row; 1978;
  69. Platt JJ. Vocational rehabilitation of drug abusers. Psychological Bulletin. 1995;117:416–433
  70. Ritter GA, Carusi C, Krenzke T, Legum SE, Mohadjer L, Reif S, et al. Phase III methodology—Client follow-up study. In: Alcohol and Drug Services Study (ADSS) methodology report: Phases I, II, and III. Rockville, MD: Substance Abuse and Mental Health Services Administration. Office of Applied Studies; 2003;[Retrieved July 31, 2006. http://www.oas.samhsa.gov/ADSS/ADSSmethods.pdf]
  71. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Archives of General Psychiatry. 1988;45:1023–1031
  72. Roudenbush SW, Bryk AS. Hierarchical linear models: Applications and data analysis methods. Thousand Oaks, CA: Sage Publications; 2002;
  73. Roy A, DeJong J, Lamparski D, George T, Linnoila M. Depression among alcoholics: Relationship to clinical and cerebrospinal fluid variables. Archives of Psychiatry. 1991;48:28–32
  74. Satre DD, Mertens J, Arean PA, Weisner C. Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. Quarterly Journal of Studies on Alcohol. 2003;64:520–530
  75. Sayre SL, Schmitz JM, Stotts AL, Averill PM, Rhoades HM, Grabowski JJ. Determining predictors of attrition in an outpatient substance abuse program. American Journal of Drug and Alcohol Abuse. 2002;28:55–72
  76. Schildhaus S, Gerstein D, Dugoni B, Brittingham A, Cerbone F. Service Research Outcome Study: Explanation of treatment effectiveness, using individual-level and programmatic variables. Substance Use and Misuse. 2000;35:1879–1910
  77. Schlesinger M, Dorward R, Epstein S. Managed care constraints in psychiatrists' hospital practices: Bargaining power and professional autonomy. American Journal of Psychiatry. 1996;153:256–260
  78. Schwartz BJ, Wetzler S. A new approach to managed care: The provider-run organization. Psychiatric Quarterly. 1998;69:345–354
  79. Sederer LI, Bennett MJ. Managed mental health care in the United States: A status report. Administration and Policy in Mental Health and Mental Health Services Research. 1996;23:289–307
  80. Sells SB. The DARP research program and data system. American Journal of Drug Alcohol Abuse. 1975;2:1–14
  81. Simpson DD. Treatment for drug abuse: Follow-up outcomes and length of time spent. Archives of General Psychiatry. 1981;38:875–880
  82. Simpson DD. A conceptual framework for drug treatment process and outcomes. Journal of Substance Abuse Treatment. 2004;27:99–121
  83. Simpson DD, Joe GW, Broome KM. A national 5-year follow-up of treatment outcomes for cocaine dependence. Archives of General Psychiatry. 2002;59:538–544
  84. Simpson DD, Sells SB. Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol and Substance Abuse. 1982;2:7–29
  85. Sosin MR. Negotiating case decisions in substance abuse managed care. Journal of Health and Social Behavior. 2002;43:277–295
  86. Sosin MR. The administrative control system of substance abuse managed care. Health Services Research. 2005;40:157–171
  87. Substance Abuse and Mental Health Services Administration . Alcohol and Drug Services Study (ADSS) methodology report: Phases I, II, and III. Rockville, MD: Office of Applied Studies; 2003;
  88. U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies . Alcohol and Drug Services Study, 1996–1999. Conducted by Brandeis University 2nd ICPSR ed. Ann Arbor, MI: Inter-university Consortium for Political and Social Research; 2002;
  89. Vendetti J, McRee B, Miller M, Christiansen K, Herrel J The Marijuana Treatment Research Group. Correlates of pre-treatment drop-out among persons with marijuana dependence. Addiction. 2002;97:125–134
  90. Walsh A. Positioning for capitation in long term care: A profile of vertical integration strategies in health and social service organizations. Journal of Health and Social Policy. 1998;10:41–51
  91. Walton MA, Castro FG, Barington EH. The role of attributions in abstinence, lapse, and relapse following substance abuse treatment. Addictive Behaviors. 1994;19:319–331
  92. Wickizer T, Maynard C, Atherfy A, Frederick M, Koepsell T, Krupski A, et al. Completion rates of clients discharged from drug and alcohol treatment programs in Washington state. American Journal of Public Health. 1994;84:215–221
  93. Wolkstein E, Spiller H. Providing vocational services to clients in substance abuse rehabilitation. Directions in Rehabilitation Counseling. 1998;9:65–77
  94. Woody GE, McLellan TA, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Archives of General Psychiatry. 1995;42:1081–1086
  95. Yoo J, Brooks D. The role of organizational variables in predicting service effectiveness: An analysis of a multilevel model. Research on Social Work Practice. 2005;15:267–277

PII: S0740-5472(07)00111-0

doi: 10.1016/j.jsat.2007.04.007

Journal of Substance Abuse Treatment
Volume 34, Issue 2 , Pages 249-262 , March 2008

Article Tools

* Image Usage & Resolution